SG11202111960PA - Method for treating endometriosis-associated pain by using diaminopyrimidine compound - Google Patents
Method for treating endometriosis-associated pain by using diaminopyrimidine compoundInfo
- Publication number
- SG11202111960PA SG11202111960PA SG11202111960PA SG11202111960PA SG11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA
- Authority
- SG
- Singapore
- Prior art keywords
- associated pain
- treating endometriosis
- diaminopyrimidine compound
- diaminopyrimidine
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019085209 | 2019-04-30 | ||
PCT/CN2020/087689 WO2020221277A1 (en) | 2019-04-30 | 2020-04-29 | Method for treating endometriosis-associated pain by using diaminopyrimidine compound |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202111960PA true SG11202111960PA (en) | 2021-12-30 |
Family
ID=73028778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202111960PA SG11202111960PA (en) | 2019-04-30 | 2020-04-29 | Method for treating endometriosis-associated pain by using diaminopyrimidine compound |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220249478A1 (en) |
EP (1) | EP3960178A4 (en) |
JP (1) | JP2022531570A (en) |
KR (1) | KR20220008286A (en) |
CN (1) | CN114007620A (en) |
AU (1) | AU2020266947A1 (en) |
BR (1) | BR112021021838A8 (en) |
CA (1) | CA3138238A1 (en) |
MX (1) | MX2021013347A (en) |
SG (1) | SG11202111960PA (en) |
TW (1) | TWI737285B (en) |
WO (1) | WO2020221277A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019085916A1 (en) * | 2017-11-01 | 2019-05-09 | 北京泰德制药股份有限公司 | P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008104474A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Diaminopyrimidines |
WO2017160569A1 (en) * | 2016-03-14 | 2017-09-21 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
EP3433258B1 (en) * | 2016-03-25 | 2023-07-19 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
WO2019085916A1 (en) * | 2017-11-01 | 2019-05-09 | 北京泰德制药股份有限公司 | P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof |
-
2020
- 2020-04-29 SG SG11202111960PA patent/SG11202111960PA/en unknown
- 2020-04-29 BR BR112021021838A patent/BR112021021838A8/en unknown
- 2020-04-29 CA CA3138238A patent/CA3138238A1/en active Pending
- 2020-04-29 MX MX2021013347A patent/MX2021013347A/en unknown
- 2020-04-29 CN CN202080032509.8A patent/CN114007620A/en active Pending
- 2020-04-29 WO PCT/CN2020/087689 patent/WO2020221277A1/en unknown
- 2020-04-29 EP EP20798599.5A patent/EP3960178A4/en active Pending
- 2020-04-29 AU AU2020266947A patent/AU2020266947A1/en active Pending
- 2020-04-29 US US17/607,475 patent/US20220249478A1/en active Pending
- 2020-04-29 KR KR1020217038622A patent/KR20220008286A/en unknown
- 2020-04-29 JP JP2021564186A patent/JP2022531570A/en active Pending
- 2020-04-30 TW TW109114698A patent/TWI737285B/en active
Also Published As
Publication number | Publication date |
---|---|
MX2021013347A (en) | 2022-01-24 |
US20220249478A1 (en) | 2022-08-11 |
WO2020221277A1 (en) | 2020-11-05 |
TW202106303A (en) | 2021-02-16 |
AU2020266947A1 (en) | 2021-12-16 |
EP3960178A4 (en) | 2023-01-25 |
JP2022531570A (en) | 2022-07-07 |
CN114007620A (en) | 2022-02-01 |
KR20220008286A (en) | 2022-01-20 |
TWI737285B (en) | 2021-08-21 |
BR112021021838A2 (en) | 2022-01-04 |
EP3960178A1 (en) | 2022-03-02 |
BR112021021838A8 (en) | 2023-02-28 |
CA3138238A1 (en) | 2020-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285496A (en) | Methods for treating cholestasis | |
GB201907244D0 (en) | Method | |
IL280128A (en) | Method for treating epilepsy | |
GB201909562D0 (en) | Method | |
SG11202106794WA (en) | Method for treating lower back pain | |
IL284951A (en) | Method for treating osteoarthritis pain by administering resiniferatoxin | |
EP4055009C0 (en) | Method for preparing dexmedetomidine | |
SG11202111960PA (en) | Method for treating endometriosis-associated pain by using diaminopyrimidine compound | |
GB201907782D0 (en) | Method | |
GB201900940D0 (en) | Method | |
GB201900647D0 (en) | Method | |
SG11202111877TA (en) | Method for treating cough by using diaminopyrimidine compound | |
SG11202111060VA (en) | Method for producing perfluoroalkyne compound | |
SG11202103673UA (en) | Method for producing perfluorocycloalkene compound | |
GB201901532D0 (en) | Method | |
EP3560571C0 (en) | Method for purifying fructose | |
EP4003390A4 (en) | Method for treating solid tumors | |
EP4051214A4 (en) | Method for treating skin | |
IL290319A (en) | Compound for combination treatment | |
EP3749616C0 (en) | Method for treating wastewater | |
GB201910244D0 (en) | Method for treating cancer | |
SG11202101291VA (en) | Method for improved poxvirus yields | |
EP4058063A4 (en) | Methods for treating diseases | |
EP3852743A4 (en) | Pyrazolylacylpyrazoline compounds and method for treating pain | |
EP3962928A4 (en) | Method for treating opioid use disorder |